Literature DB >> 10028088

Additional reports of failure to respond to treatment after rabies exposure in Thailand.

T Hemachudha1, E Mitrabhakdi, H Wilde, A Vejabhuti, S Siripataravanit, D Kingnate.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10028088     DOI: 10.1086/517179

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

Review 1.  Substandard/counterfeit antimicrobial drugs.

Authors:  Theodoros Kelesidis; Matthew E Falagas
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

2.  Rabies encephalitis in a child: a failure of rabies post exposure prophylaxis?

Authors:  Faten Tinsa; Aida Borgi; Imen Jahouat; Khadija Boussetta
Journal:  BMJ Case Rep       Date:  2015-01-14

3.  Feasibility of reducing rabies immunoglobulin dosage for passive immunization against rabies: results of In vitro and In vivo studies.

Authors:  Shampur Narayan Madhusudana; Belludi Yajaman Ashwin; Sampada Sudarshan
Journal:  Hum Vaccin Immunother       Date:  2013-06-21       Impact factor: 3.452

4.  Epidemiology and molecular virus characterization of reemerging rabies, South Africa.

Authors:  Cheryl Cohen; Benn Sartorius; Claude Sabeta; Gugulethu Zulu; Janusz Paweska; Mamokete Mogoswane; Chris Sutton; Louis H Nel; Robert Swanepoel; Patricia A Leman; Antoinette A Grobbelaar; Edwin Dyason; Lucille Blumberg
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

5.  Challenges facing human rabies control: the Lebanese experience.

Authors:  A Bizri; A Alawieh; N Ghosn; A Berry; U Musharrafieh
Journal:  Epidemiol Infect       Date:  2013-09-25       Impact factor: 4.434

6.  Mechanism of protection induced by group A Streptococcus vaccine candidate J8-DT: contribution of B and T-cells towards protection.

Authors:  Manisha Pandey; Michael R Batzloff; Michael F Good
Journal:  PLoS One       Date:  2009-04-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.